Eargo Announces Closing of Rights Offering and Conversion of Patient Square Notes Into Shares of Eargo Common Stock
SAN JOSE, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) — Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ:EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, announced today the closing and final results of its rights offering, which expired at 5:00 p.m. New York City time, on November 17, 2022.
Related news for (EAR)
- Ellington Credit Company Reports Preliminary Fourth Quarter 2024 Results and Provides Conversion Update
- Turtle Beach Corporation Announces Ticker Symbol Update to “TBCH”
- Ellington Credit Company Reports Third Quarter 2024 Results
- turtle beach corporation to report third quarter 2024 financial results on thursday, november 7, 2024
- turtle beach drives growth in key international markets, including canada and key territories in latin america
